Literature DB >> 31107497

Flexible Modeling of the Association Between Cumulative Exposure to Low-Dose Ionizing Radiation From Cardiac Procedures and Risk of Cancer in Adults With Congenital Heart Disease.

Coraline Danieli1,2, Sarah Cohen2,3, Aihua Liu2,3, Louise Pilote2,4, Liming Guo2,3, Marie-Eve Beauchamp2, Ariane J Marelli2,3, Michal Abrahamowicz1,2.   

Abstract

Adults with congenital heart disease are increasingly being exposed to low-dose ionizing radiation (LDIR) from cardiac procedures. In a recent study, Cohen et al. (Circulation. 2018;137(13):1334-1345) reported an association between increased LDIR exposure and cancer incidence but did not explore temporal relationships. Yet, the impact of past exposures probably accumulates over years, and its strength may depend on the amount of time elapsed since exposure. Furthermore, LDIR procedures performed shortly before a cancer diagnosis may have been ordered because of early symptoms of cancer, raising concerns about reversal causality bias. To address these challenges, we combined flexible modeling of cumulative exposures with competing-risks methodology to estimate separate associations of time-varying LDIR exposure with cancer incidence and all-cause mortality. Among 24,833 patients from the Quebec Congenital Heart Disease Database, 602 had incident cancer and 500 died during a follow-up period of up to 15 years (1995-2010). Initial results suggested a strong association of cancer incidence with very recent LDIR exposures, likely reflecting reverse causality bias. When exposure was lagged by 2 years, an increased cumulative LDIR dose from the previous 2-6 years was associated with increased cancer incidence, with a stronger association for women. These results illustrate the importance of accurate modeling of temporal relationships between time-varying exposures and health outcomes.
© The Author(s) 2019. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  cancer epidemiology; competing risks; splines; time-varying exposure

Year:  2019        PMID: 31107497      PMCID: PMC6670051          DOI: 10.1093/aje/kwz114

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  63 in total

1.  Using splines to analyse latency in the Colorado Plateau uranium miners cohort.

Authors:  M Hauptmann; K Berhane; B Langholz; J Lubin
Journal:  J Epidemiol Biostat       Date:  2001

2.  Estimating the distribution of lag in the effect of short-term exposures and interventions: adaptation of a non-parametric regression spline model.

Authors:  B Rachet; M Abrahamowicz; A J Sasco; J Siemiatycki
Journal:  Stat Med       Date:  2003-07-30       Impact factor: 2.373

3.  Methodological problems of time-related variables in occupational cohort studies.

Authors:  N Pearce
Journal:  Rev Epidemiol Sante Publique       Date:  1992       Impact factor: 1.019

4.  Ionizing radiation in cardiac imaging: a science advisory from the American Heart Association Committee on Cardiac Imaging of the Council on Clinical Cardiology and Committee on Cardiovascular Imaging and Intervention of the Council on Cardiovascular Radiology and Intervention.

Authors:  Thomas C Gerber; J Jeffrey Carr; Andrew E Arai; Robert L Dixon; Victor A Ferrari; Antoinette S Gomes; Gary V Heller; Cynthia H McCollough; Michael F McNitt-Gray; Fred A Mettler; Jennifer H Mieres; Richard L Morin; Michael V Yester
Journal:  Circulation       Date:  2009-02-02       Impact factor: 29.690

5.  Assessing the effect of intensity when exposure varies over time.

Authors:  P M Vacek
Journal:  Stat Med       Date:  1997-03-15       Impact factor: 2.373

6.  Applying Cox regression to competing risks.

Authors:  M Lunn; D McNeil
Journal:  Biometrics       Date:  1995-06       Impact factor: 2.571

7.  Cancer risk related to low-dose ionizing radiation from cardiac imaging in patients after acute myocardial infarction.

Authors:  Mark J Eisenberg; Jonathan Afilalo; Patrick R Lawler; Michal Abrahamowicz; Hugues Richard; Louise Pilote
Journal:  CMAJ       Date:  2011-02-07       Impact factor: 8.262

8.  A molecular fingerprint for medulloblastoma.

Authors:  Youngsoo Lee; Heather L Miller; Patricia Jensen; Roberto Hernan; Michele Connelly; Cynthia Wetmore; Frederique Zindy; Martine F Roussel; Tom Curran; Richard J Gilbertson; Peter J McKinnon
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701

9.  Solid cancer incidence in atomic bomb survivors: 1958-1998.

Authors:  D L Preston; E Ron; S Tokuoka; S Funamoto; N Nishi; M Soda; K Mabuchi; K Kodama
Journal:  Radiat Res       Date:  2007-07       Impact factor: 2.841

10.  Exposure to Low-Dose Ionizing Radiation From Cardiac Procedures and Malignancy Risk in Adults With Congenital Heart Disease.

Authors:  Sarah Cohen; Aihua Liu; Michelle Gurvitz; Liming Guo; Judith Therrien; Claudie Laprise; Jay S Kaufman; Michal Abrahamowicz; Ariane J Marelli
Journal:  Circulation       Date:  2017-12-21       Impact factor: 29.690

View more
  3 in total

1.  Latency estimation for chronic disease risk: a damped exponential weighting model.

Authors:  Karin Michels; Mingyang Song; Walter C Willett; Bernard Rosner
Journal:  Eur J Epidemiol       Date:  2020-07-30       Impact factor: 8.082

2.  Risk of cancer in young and older patients with congenital heart disease and the excess risk of cancer by syndromes, organ transplantation and cardiac surgery: Swedish health registry study (1930-2017).

Authors:  Christina Karazisi; Mikael Dellborg; Karin Mellgren; Kok Wai Giang; Kristofer Skoglund; Peter Eriksson; Zacharias Mandalenakis
Journal:  Lancet Reg Health Eur       Date:  2022-05-29

3.  Nurse staffing practices and adverse events in acute care hospitals: The research protocol of a multisite patient-level longitudinal study.

Authors:  Christian M Rochefort; Michal Abrahamowicz; Alain Biron; Patricia Bourgault; Isabelle Gaboury; Jeannie Haggerty; Jane McCusker
Journal:  J Adv Nurs       Date:  2020-12-10       Impact factor: 3.187

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.